DEA Finalizes Prescription Opioid Anti-Diversion Policy
The U.S. Drug Enforcement Administration finalized plans Wednesday to scrutinize diversion of prescription opioids for illicit uses when setting limits on opioid production, shooting down industry objections about potential shortages and...To view the full article, register now.
Already a subscriber? Click here to view full article